Background:Oxidative stress is characterized by increased production of reactive oxygen species resulting in the generation of lipid peroxides such as malondialdehyde (MDA). The studies have shown that ischemia-modified albumin (IMA), which has widely been studied as a marker of ischemia, also increases as result of oxidative stress. Hence, the current study was done to evaluate the serum MDA, IMA along with serum uric acid, and albumin, which are important metabolic antioxidants.Materials and Methods:Fifty patients with acute ischemic stroke were taken as cases and compared with 50 age- and sex-matched controls. Serum MDA, IMA, uric acid, and albumin were estimated both in cases and controls. Serum MDA was estimated by the method of Satoh and IMA by Bar-Or et al. The results were analyzed statistically.Results:Serum MDA and IMA values were significantly increased in cases (P < 0.0001), whereas serum uric acid and albumin values were significantly decreased (P < 0.05) in comparison to controls. There was also highly significant positive correlation between serum IMA and MDA (r = 0.843,P < 0.0001), whereas there were significant negative correlations between serum IMA and uric acid (r = −0.237,P < 0.05), and albumin (r = −0.326,P < 0.05).Conclusion:Hence, we conclude the oxidative stress plays a major role in the etiopathogenesis of acute ischemic stroke, and the deranged oxidant-antioxidant balance further contributes to its severity.
Cite this article as: Rana AK, Ray S. Dyselectrolytemia in hyperglycaemic crisis patients with uncontrolled non-insulin dependent diabetes mellitus. Int J Res Med Sci 2017;5:478-81.
Alkaline Phosphatase (ALP) enzyme activity is usually measured as a part of liver function test (LFT) to detect increases in its activity. Less attention has been put to know the conditions associated with decreases in its activity. Micronutrients like Zinc (Zn) and Magnesium (Mg) are important causes of low ALP activity. Our Objective is to find out Zn and Mg deficiencies as important cause of decrease in ALP activity and to initiate supplementation of these minerals. The study was done to assess Zn and Mg deficiency in 42 persons having low ALP activity and 45 healthy controls. Correlation between minerals and ALP activities were also carried out. It was found that 52.38% of cases are Mg deficient and 47.62% cases are Zn deficient. A significant decrease in Zn and Mg was observed in low ALP cases when compared with control (p<0.001, p<0.05). Significant positive correlation was found between the minerals and ALP. Serum Zn and Mg are essential for human body and by screening their deficiency, supplementation of minerals can be initiated.
Background: Psoriasis although a disease of the skin has been reported to be associated with metabolic syndrome. Metabolic syndrome in turn is associated with dyslipidemia which is a independent risk factor for cardiovascular diseases. Our study therefore aims to assess lipid profile in patients with psoriasis with an objective to observe and report any significant deviations in the same as compared to healthy controls.Methods: 25 patients with psoriasis and 25 age, sex matched healthy controls were recruited in this study and lipid profile was estimated using commercially available reagent kit which employs the CHOD-PAP method.Results: Significant elevation in levels of total cholesterol, triglycerides, VLDL and cholesterol/HDL ratio was observed. Elevated although was observed in case of LDL and HDL levels, but it was statistically insignificant.Conclusions: Dyslipidemia was found to be prevalent in psoriasis patients. Dyslipidemia is an independent risk factor for development of cardiovascular disease. Dyslipidemia in psoriasis therefore clearly suggests an inherent predisposition of psoriasis patients to suffer from cardiovascular diseases. A lipid profile estimation in these patients therefore might serve as an important tool for risk assessment for cardiovascular disease, thereby aiding a timely intervention.
<p>ABSTRACT<br />Objective: Hypertension is the most common cardiovascular disease and one of the most important public health concerns all over the world. Primary<br />or essential hypertension is the major form of arterial hypertension without any definitive cause. It results from increase vascular tone and resistance<br />which may be confined to the lower level of endothelial derived relaxing factor such as nitric oxide (NO). Hence, the objective of this study is to find<br />out whether any correlation exists between the concentrations of serum NO (nitrite) and essential hypertensive patients categorized according to the<br />Joint National Committee 7 classification.<br />Methods: We selected age- and sex-matched 24 healthy individuals as controls and 35 essential hypertensive patients as cases. Out of 35 cases, 24<br />were included in stage 1 and 11 in stage 2 of essential hypertension. We estimated serum NO levels in study groups basing on the principle of Griess<br />reaction.<br />Results: We observed reduction in mean serum NO level in cases which was statistically highly significant as compared to controls (8.14±0.33 vs.<br />13.53±0.38 µmol/L, p<0.001) and also in stage 2 patients when compared with stage 1 patients (5.97±0.31 vs. 9.15±0.28 µmol/L, p<0.001). In<br />hypertensive patients, serum NO showed a highly significant inverse correlation to both systolic (r=−0.89, p<0.001) as well as diastolic (r=−0.64,<br />p<0.001) blood pressure.<br />Conclusion: Thus, we can conclude that lower level of serum NO can be an important causative factor in the progress of essential hypertension.<br />Keywords: Essential hypertension, Endothelial-derived relaxing factor, Nitric oxide, Joint National Committee 7.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.